ARCHIVES

Dendreon’s Provenge Approved For Prostate Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

DCT Board Approves Drug Development Recompetition

November 30, 1990

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

Obit: Same Shapiro, Proponent of Mammographic Screening.

January 7, 2000

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009